Investors question premium in Merck's $6.7B deal for Terns Pharma - analyst
Terns Pharmaceuticals, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $52.95
+0.2% since the alert
$52.86 → $52.95
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS